Quick Answer
Zinc Mood Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: 1 2 3 4 1 4 5 6 7 L-carnosine (β-alanyl-L-histidine) is a naturally occurring bioactive dipeptide composed of β-alanine and L-histidine, predominantly found in tissues with high metabolic demands such as skeletal muscle and the central nervous system [,].
Key Takeaways
- 011 2 3 4 1 4 5 6 7 L-carnosine (β-alanyl-L-histidine) is a naturally occurring bioactive dipeptide composed of β-alanine and L-histidine, predominantly found in tissues with high metabolic demands such as skeletal muscle and the central nervous system [,]. [Hsiao Yung-Fang (2026)]
- 02Age-associated declines in muscle carnosine content have been associated with reduced exercise capacity and increased fatigue, whereas reductions in brain carnosine levels have been linked to oxidative damage, protein aggregation, and cognitive impairment in neurodegenerative conditions or aging [,,]. [Hsiao Yung-Fang (2026)]
- 03The goal of this scoping review is to identify research areas for which sufficient evidence warrants a systematic review (SR) and meta-analysis. [Hsiao Yung-Fang (2026)]
- 04Mediated by carnosine synthase, the endogenous synthesis of L-carnosine is rate-limited by the availability of β-alanine [,]. [Hsiao Yung-Fang (2026)]
The current Migaku evidence database contains 2 reusable source documents for Zinc Mood Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts.
- 1 2 3 4 1 4 5 6 7 L-carnosine (β-alanyl-L-histidine) is a naturally occurring bioactive dipeptide composed of β-alanine and L-histidine, predominantly found in tissues with high metabolic demands such as skeletal muscle and the central nervous system [,]. [Hsiao Yung-Fang (2026); evidence level 1]
- Age-associated declines in muscle carnosine content have been associated with reduced exercise capacity and increased fatigue, whereas reductions in brain carnosine levels have been linked to oxidative damage, protein aggregation, and cognitive impairment in neurodegenerative conditions or aging [,,]. [Hsiao Yung-Fang (2026); evidence level 1]
- The goal of this scoping review is to identify research areas for which sufficient evidence warrants a systematic review (SR) and meta-analysis. [Hsiao Yung-Fang (2026); evidence level 1]
- Mediated by carnosine synthase, the endogenous synthesis of L-carnosine is rate-limited by the availability of β-alanine [,]. [Hsiao Yung-Fang (2026); evidence level 1]
- A comprehensive review of psychiatric presentations reported that psychiatric symptoms span attention problems, anxiety, mood/behavioral disorders, and psychosis and identified > 100 IEMs associated with psychiatric manifestations; in a curated analysis, 94 IEMs were linked to psychiatric symptoms, with mood changes ranging from depressive syndromes to bipolar-like presentations []. [Hachmeriyan Antoniya (2026); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources